EN IT

Reserved

XLC slips 1.4% and stays below resistance at 113.5

·46 min read
EXECUTIVE VIEW

The buy signal on XLC has been open for 5 weeks but Strength drops to 27: contracting volume and an ongoing distribution phase keep price away from the 113.5 breakout.

Reserved analysis Subscribe to read →
Reserved

XLB climbs 1.9% as the MACD crosses back above Signal after 15 weeks

·46 min read
EXECUTIVE VIEW

XLB, the US materials sector ETF: weekly technical analysis as the MACD crosses back above Signal after 15 weeks and buyers regain control. Price action shows a buy signal in play, trade up 3% since entry.

Reserved analysis Subscribe to read →
Reserved

TeraWulf sheds 10% as sellers retake control of the tape

·46 min read
EXECUTIVE VIEW

TeraWulf sheds 10% in a rough week: sellers retake control of trading and the daily lower-highs pattern keeps stretching. The Sell signal, open for 7 weeks, still holds the upper hand according to our model.

Reserved analysis Subscribe to read →
Reserved

Walmart sheds 10% after earnings as sellers retake control

·45 min read
EXECUTIVE VIEW

Walmart drops 10% during earnings week: sell volume at 89%, RSI falling, MACD worsening and momentum deeply negative. The weekly price action confirms sellers back in control after the prior week's bounce.

Reserved analysis Subscribe to read →
Reserved

Wells Fargo stock drops 5.6%, yet the weekly structure holds

·47 min read
EXECUTIVE VIEW

Weekly technical analysis on Wells Fargo stock: a 5.6% weekly drop, yet three of four moving averages stay aligned. Among financial stocks, this buy signal is in its 11th week, with the stop already past breakeven protecting the gain.

Reserved analysis Subscribe to read →
Reserved

Western Digital drops 9.7% as sellers regain control

·46 min read
EXECUTIVE VIEW

Western Digital's Sell signal enters its eighth week: after last week's 17.2% bounce, sellers take back control of volume, the MACD widens its gap from the Signal line, and the price works between nearby support and resistance.

Reserved analysis Subscribe to read →
Reserved

Verizon stock gains 2% and keeps knocking on the 49.7 breakout level

·46 min read
EXECUTIVE VIEW

Verizon stock gains 2% in the third week of its buy signal and stays just short of the 49.7 area, the level that would open the door to a breakout. The MACD keeps improving, but thin volumes and rejection candles still call for caution.

Reserved analysis Subscribe to read →
Reserved

VXUS closes the week flat at 0%, but the MACD turns bullish and money flow returns

·46 min read
EXECUTIVE VIEW

VXUS, the Vanguard international ex-US stock ETF, weekly technical analysis: the MACD turns bullish, money flow swings back to buying, and the trade, open 19 weeks, runs at +7.92% since entry — a swing trading case worth watching.

Reserved analysis Subscribe to read →
Reserved

Vanguard FTSE Emerging Markets climbs 0.6%, but the trend is losing conviction

·46 min read
EXECUTIVE VIEW

Vanguard FTSE Emerging Markets recovers last week's 0.6% drop on strong buy volume, but the ADX has fallen for 9 weeks and the trend is losing conviction: technical analysis and key levels for the emerging-markets ETF.

Reserved analysis Subscribe to read →
Reserved

VTI slips 1.5%, snapping a 3-week rally, but the trend holds

·46 min read
EXECUTIVE VIEW

VTI, the ETF that tracks the entire US stock market, weekly technical analysis: the rally pauses after 3 weeks as sellers regain control, though money flow stays positive for a 15th week and the trade sits at +12.89% since entry.

Reserved analysis Subscribe to read →
Reserved

VT slips 0.9%, snapping a three-week rally, but the trend holds

·46 min read
EXECUTIVE VIEW

VT, the Vanguard ETF tracking the entire global stock market, pauses after three weeks of gains. Weekly technical analysis: RSI cooling, money flow still positive, and the model's coverage now complete with all three targets hit.

Reserved analysis Subscribe to read →
Reserved

Vertex Pharmaceuticals stock gains 8.4% and nears its all-time highs

·46 min read
EXECUTIVE VIEW

Vertex Pharmaceuticals stock technical analysis: the buy signal is in its 9th week, up 21.4% since entry. The week closed +8.4%, near all-time highs, with weekly RSI approaching overbought - a swing trading setup worth watching.

Reserved analysis Subscribe to read →
Reserved

Vertiv drops 10.9% as the Sell signal reclaims the upper hand

·46 min read
EXECUTIVE VIEW

Vertiv weekly technical analysis: the stock drops 10.9% after a sharp rejection at the 300 area, as sellers retake control. The Sell signal, under management for 12 weeks, stays more than 17% in the money.

Reserved analysis Subscribe to read →
Reserved

Valero Energy stock rises 2.1%, tests highs with capital up 88%

·46 min read
EXECUTIVE VIEW

Valero stock technical analysis: the energy stock extends its run, testing highs near 353 with RSI at 75 and the ADX rising for seven weeks. The trade's residual capital is up 88.29%, with the stop trailing the Inversion Point.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn